Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
The Arctic Pharma Family Is Growing
Posted on March 31st, 2017 by Claudia A. McDonald Bøen, Ph.D. in Pharma R&D
Just as some members of our team are going off on parental leave to grow their families, our Arctic Pharma research family is also getting bigger. We have recently expanded the Arctic team by bringing on board three very talented scientists.
Elahe is an organic chemist trained in Norway. She will be working closely with Bora to increase our inventory of inhibitors. Her main duties will be to synthesize new inhibitors and modify existing ones using methods of medicinal chemistry to increase their potency and other selected biochemical characteristics such as solubility and selectivity.
Kathrin recently graduated with her PhD from the University of Oslo. She has a broad wealth of knowledge and experience as she is a trained biochemist, immunologist and chemist. She will be working with Steffi in developing new biochemical assays to characterize our most promising inhibitors. Kathrin will also work on solving the x-ray structure of our target enzyme in complex with its cofactor and our “best” inhibitors.
Anja obtained her doctoral training from the Max Planck Institute for Experimental Medicine in Göttingen, Germany in neurophysiology and molecular biology. She has more than 20 years of experience in the fields of molecular biology, cell biology and biochemistry. Anja will be developing strategies for testing our drug candidates using cellular based assays and molecular biology. She will also design predictive disease-relevant cell/tissue culture models such as three-dimensional cultures like mammary spheres.
We’re confident all three of these new team members will have much to contribute to our work at Arctic Pharma. But, like anyone else, scientists also have hobbies beyond the lab. When Elahe, Kathrin and Anja are away from the bench, they enjoy doing outdoor activities such as skiing—which is perfectly set in our beautiful Norwegian landscape.
Read about how Elsevier’s suite of Solutions for Life Sciences is enabling start-ups like Arctic.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Claudia A. McDonald Bøen, Ph.D.
CEO at Arctic Pharma
- Chemists Concerned About How Their Field is Viewed
- As The Hive Evolves, More Companies Prepare to Join the Program
- Seeking Other Perspectives to Tease Out New Innovations
- Myelo Therapeutics Takes on Unmet Needs in Cancer
- Chemists: Unsung Innovators